Notify me when Aisling Capital LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2019 | 4 | $45,282,000 | $0 | -$15,963,696 | -$15,963,696 | AIMT, ADMA, CDTX, TRXC | 13F-HR | 13 Nov 2019, 16:07 |
| Q2 2019 | 4 | $60,338,000 | $0 | $0 | $0 | AIMT, ADMA, TRXC, CDTX | 13F-HR | 07 Aug 2019, 20:26 |
| Q1 2019 | 4 | $66,545,000 | $0 | -$289,118,000 | -$289,118,000 | AIMT, ADMA, TRXC, CDTX | 13F-HR | 07 May 2019, 16:05 |
| Q4 2018 | 9 | $353,143,000 | $0 | -$8,329,040 | -$8,329,040 | LOXO, AIMT, ADMA, TRXC, CDTX | 13F-HR | 11 Feb 2019, 16:08 |
| Q3 2018 | 9 | $462,740,000 | $0 | -$322,954,533 | -$322,954,533 | LOXO, AIMT, ADMA, VRAYQ, TRXC | 13F-HR | 05 Nov 2018, 11:25 |
| Q2 2018 | 9 | $761,879,000 | $0 | -$18,614,233 | -$18,614,233 | LOXO, AIMT, VRAYQ, TRXC, ADMA | 13F-HR | 13 Aug 2018, 10:36 |
| Q1 2018 | 10 | $561,114,000 | $0 | -$17,842,000 | -$17,842,000 | LOXO, AIMT, VRAYQ, TRXC, ADMA | 13F-HR | 14 May 2018, 10:29 |
| Q4 2017 | 12 | $506,190,000 | $0 | -$135,663,562 | -$135,663,562 | LOXO, AIMT, VRAYQ, TRXC, ENTL | 13F-HR | 07 Feb 2018, 16:19 |
| Q3 2017 | 13 | $608,709,000 | +$9,759,000 | -$16,523,000 | -$6,764,000 | LOXO, AIMT, VRAYQ, ESPR, TRXC | 13F-HR | 09 Nov 2017, 08:51 |
| Q2 2017 | 15 | $548,545,000 | +$1,419,917 | -$97,571,682 | -$96,151,765 | LOXO, AIMT, VRAYQ, ESPR, ADMA | 13F-HR | 14 Aug 2017, 09:40 |
| Q1 2017 | 17 | $549,262,000 | +$6,732,809 | -$42,264,030 | -$35,531,221 | LOXO, ZLTQ, AIMT, VRAYQ, VSAR | 13F-HR | 10 May 2017, 17:01 |
| Q4 2016 | 18 | $430,137,000 | +$407,000 | -$49,731,323 | -$49,324,323 | LOXO, ZLTQ, AIMT, VSAR, VRAYQ | 13F-HR | 13 Feb 2017, 16:16 |
| Q3 2016 | 20 | $485,393,000 | +$7,107,741 | -$44,788,900 | -$37,681,159 | LOXO, ZLTQ, CYNA, AIMT, VRAYQ | 13F-HR | 10 Nov 2016, 16:31 |
| Q2 2016 | 22 | $423,454,000 | +$23,935,658 | -$37,986,018 | -$14,050,360 | LOXO, ZLTQ, AIMT, VRAYQ, VSAR | 13F-HR | 12 Aug 2016, 16:10 |
| Q1 2016 | 22 | $499,392,000 | +$35,188,059 | -$17,594,927 | +$17,593,132 | LOXO, ZLTQ, AIMT, TRXC, VRAYQ | 13F-HR | 13 May 2016, 16:16 |
| Q4 2015 | 22 | $579,832,000 | +$16,991,950 | -$29,616,843 | -$12,624,893 | LOXO, CEMP, ZLTQ, AIMT, ESPR | 13F-HR | 10 Feb 2016, 17:00 |
| Q3 2015 | 22 | $568,822,000 | +$101,947,000 | $0 | +$101,947,000 | ZLTQ, AIMT, CEMP, LOXO, ESPR | 13F-HR | 13 Nov 2015, 16:07 |
| Q2 2015 | 18 | $0 | $0 | $0 | $0 | 13F-HR | 14 Aug 2015, 16:15 | |
| Q1 2015 | 18 | $38,932 | $0 | $0 | $0 | ADMA, EVAR | 13F-HR | 11 May 2015, 16:31 |
| Q4 2014 | 19 | $0 | $0 | $0 | $0 | 13F-HR | 13 Feb 2015, 16:06 | |
| Q3 2014 | 18 | $0 | $0 | $0 | $0 | Restatement | 17 Nov 2014, 16:10 | |
| Q2 2014 | 13 | $344,798,000 | +$260,038,000 | $0 | +$260,038,000 | VSAR, TRXC, ZLTQ, CEMP, DRTX | Restatement | 12 Sep 2014, 16:16 |
| Q1 2014 | 5 | $0 | $0 | $0 | $0 | 13F-HR | 13 May 2014, 16:02 | |
| Q4 2013 | 6 | $163,600,000 | $0 | $0 | $0 | Q, DRTX, CMRX, ICPT, MEI Pharma, Inc. | 13F-HR | 13 Feb 2014, 16:15 |